Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies
Susanna Bianzano, Andrea Henrich, Lena Herich, Brigitte Kalsch, Donald Sarubbi, Friedeborg Seitz, Thomas Först
Topics & Concepts
GhrelinMedicineOverweightCohortPlaceboInternal medicineAppetiteAdverse effectObesityWeight lossEndocrinologyGastroenterologyPharmacologyHormonePathologyAlternative medicineRegulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesPeroxisome Proliferator-Activated Receptors